These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9890738)

  • 1. Management of the patient with progressive radioiodine non-responsive disease.
    Haugen BR
    Semin Surg Oncol; 1999; 16(1):34-41. PubMed ID: 9890738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma.
    Coelho SM; Vaisman F; Buescu A; Mello RC; Carvalho DP; Vaisman M
    Braz J Med Biol Res; 2011 Jan; 44(1):73-7. PubMed ID: 21085896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research.
    Sarlis NJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):103-15. PubMed ID: 12476792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the thyroid cancer patient with extracervical metastases.
    Haugen BR; Kane MA
    J Clin Endocrinol Metab; 2010 Mar; 95(3):987-93. PubMed ID: 20203334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy.
    Kim JH; Leeper RD
    Cancer; 1987 Nov; 60(10):2372-5. PubMed ID: 3664425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive management of thyroid cancer: chemotherapy.
    Shimaoka K
    J Surg Oncol; 1980; 15(3):283-6. PubMed ID: 6159502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.
    Jarzab B; Handkiewicz-Junak D; Roskosz J; Puch Z; Wygoda Z; Kukulska A; Jurecka-Lubieniecka B; Hasse-Lazar K; Turska M; Zajusz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1077-86. PubMed ID: 12783219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer.
    Kebebew E; Lindsay S; Clark OH; Woeber KA; Hawkins R; Greenspan FS
    Thyroid; 2009 Sep; 19(9):953-6. PubMed ID: 19678746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.
    Teunissen JJ; Kwekkeboom DJ; Kooij PP; Bakker WH; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():107S-14S. PubMed ID: 15653659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.
    Narayanan S; Colevas AD
    Curr Treat Options Oncol; 2016 Jun; 17(6):30. PubMed ID: 27139457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
    Beckham TH; Romesser PB; Groen AH; Sabol C; Shaha AR; Sabra M; Brinkman T; Spielsinger D; McBride S; Tsai CJ; Riaz N; Tuttle RM; Fagin JA; Sherman EJ; Wong RJ; Lee NY
    Thyroid; 2018 Sep; 28(9):1180-1189. PubMed ID: 30105947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy.
    Morris JC; Kim CK; Padilla ML; Mechanick JI
    Thyroid; 1997 Feb; 7(1):63-6. PubMed ID: 9086573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.
    Simon D; Körber C; Krausch M; Segering J; Groth P; Görges R; Grünwald F; Müller-Gärtner HW; Schmutzler C; Köhrle J; Röher HD; Reiners C
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):775-82. PubMed ID: 12029551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy alternatives in the treatment of thyroid cancer.
    O'Doherty MJ; Coakley AJ
    Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current role of targeted therapies to induce radioiodine uptake in thyroid cancer.
    Fröhlich E; Wahl R
    Cancer Treat Rev; 2014 Jun; 40(5):665-74. PubMed ID: 24485648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot study.
    Stokkel MP; Verkooijen RB; Bouwsma H; Smit JW
    Nucl Med Commun; 2004 Jul; 25(7):683-90. PubMed ID: 15208495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapy in radioiodine refractory thyroid cancer.
    Pacini F; Brilli L; Marchisotta S
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
    Chow LQ; Santana-Davila R; Pantel A; Roth M; Anderson LN; Failor A; Doot R; Mankoff D
    PLoS One; 2017; 12(6):e0178325. PubMed ID: 28662033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.